Cancer Research
-
Nobel Laureate Dr. James Allison’s CTLA-4 discovery launched immunotherapy
HOUSTON, July 10 — The man who taught the immune system to fight cancer has spent the better part of three decades…
-
CAR-T Therapy Reprograms Patients’ Immune Cells to Fight Cancer
ISLAMABAD, July 10 — For patients and families facing blood cancers, the word “remission” carries a weight that is both fragile and…
-
Checkpoint Inhibitors: The Science Behind Immunotherapy’s Cancer Success
CHICAGO, July 10 — For the millions of families touched by cancer, the word “immunotherapy” once felt like a distant promise. Today,…
-
New Cancer Drugs Boost Survival 40% in Late-Stage Trials
LONDON, July 10 — The technical reality of cancer immunotherapy is that it harnesses the body’s immune system to fight cancer. Under…
-
New Study Targets GATA6 to Prevent Colorectal Cancer Spread
NEW YORK, July 8 — A study published June 22 in the journal *Cell Stem Cell* has identified a molecular mechanism that…
-
Researchers uncover how colorectal cancer cells spread to other organs
NEW YORK, July 8 — A newly published study from researchers at Weill Cornell Medicine and the Massachusetts Institute of Technology has…
-
Marine-Derived Cancer Drugs Move from Ocean to Medicine Pipeline
MANILA, July 8 — A tiny creature living in the icy waters off Antarctica could one day offer new hope in the…
-
Antarctic Marine Life Yields New Medical Breakthroughs
ROME, July 8 — Against this backdrop of a frozen continent where life clings to the edges of survival, scientists have discovered…
-
Sea Squirt Compound Shows Promise Against Melanoma Cells
NEW YORK, July 8 — 1%. That figure that matters: melanoma accounts for about 1% of all skin cancers, yet it causes…
-
Sea Squirt from Antarctic Depths Holds Promise for Melanoma Treatment
ANTARCTICA, July 8 — A marine organism discovered during a scientific expedition to Antarctica is now being studied as a potential new…
-
Senolytics: Clearing Senescent Cells to Combat Age-Related Disease
ROCHESTER, Minnesota, July 8 — For a field that began with a single question about aging cells, senolytic research has come a…
-
New CAR-T Therapy Shows 83% Remission in Aggressive Blood Cancers
MANILA, July 7 — For families across the region watching loved ones battle blood cancers that keep returning, a new treatment option…
-
Rye pollen compounds’ structures unlocked after decades for cancer research
CHICAGO, July 7 — Nearly 30 years ago, researchers discovered two unusual molecules in rye pollen that appeared to slow tumor growth…
-
Academic Pioneers to Pharma Giants Drive CAR-T Therapy
PHILADELPHIA, July 7, 2026 — Dr. Carl June, director of the Center for Cellular Immunotherapies at the University of Pennsylvania, is widely…
-
CAR-T Therapy Market: Leaders, Sales, and Global Reach in 2023
ISLAMABAD, July 7 — The global market for CAR-T cell therapy, a personalized cancer treatment that reprograms a patient’s own immune cells…
-
Funding Injection Aims to Unclog Cancer Trial Pipeline
CALGARY, July 7 — A $35 million investment announced July 6 will expand infrastructure and operational support for the Riddell Centre for…
-
Wendy Beauchesne Leads Transformational Alberta Cancer Trial Investment
EDMONTON, July 7 — Wendy Beauchesne has spent the last six years at the helm of the Alberta Cancer Foundation, and on…
-
Alberta unveils 10-year cancer plan with $35M for clinical trials
EDMONTON, July 7 — The Alberta Cancer Foundation has committed $35 million to support Alberta’s newly launched 10-Year Cancer Care Strategy, a…
-
UK Funds Prostate Cancer Early Detection & Treatment
LONDON, July 7 — A charity dedicated to tackling the most common cancer in men is hoping a new fundraising drive will…
-
Trek 500 Raises Hope and Funds in Prostate Cancer Fight
LONDON, July 7 — When Sir Chris Hoy, a six-time Olympic gold medalist and 11-time world champion cyclist, retired from competitive cycling,…
-
Owerko Centre Expands Clinical Trials with $35M Investment
CALGARY, July 7 — A major investment announced yesterday is set to transform how quickly families across Alberta, and potentially beyond, can…
-
Methylation Patterns as Cancer Hallmarks: Patent Science Explained
BANGALORE, July 7 — A new patented technology from Strand Life Sciences is changing how doctors look for cancer in its earliest,…
-
Emily Whitehead, first child treated with CAR-T in 2012, remains cancer-free
PHILLIPSBURG, N.J., July 7 — In the long, often heartbreaking history of childhood cancer research, there are a handful of moments that…
-
Woman denied breast cancer gene test for decade gets tumor diagnosis
BROADWAY, July 7 — The shift is quiet, personal, and it happens in doctors’ offices long before it reaches a headline. For…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Legal Battles Over Cancer Funding Delay Life-Saving Care for Patients
-
Stanford Digital Twins Identify Drug Combo To Stop Premature Birth
-
Why Microsatellite Instability Status Dictates Rectal Cancer Treatment Choices
-
Why KRAS Was Considered Undruggable for Decades and What Finally Cracked It
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
How Private Credit Facilities Expand Access to Affordable Consumer Lending
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds
























